U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Combination Products
  3. Jurisdictional Information
  4. RFD Jurisdictional Decisions
  5. Capsular Decisions - Products Assigned to CDER
  1. RFD Jurisdictional Decisions

Capsular Decisions - Products Assigned to CDER

A. Drugs

  • Ultrasound contrast agent
  • Dye mouthrinse to examine oral tissue
  • Orally administered drug for ultrasound imaging
  • Drug used to determine plasma volume
  • Inhaled chemoirritant to elicit cough reflex
  • Hormone for the treatment of gastrointestinal disease
  • Vital dye for ophthalmic use
  • Aerosolized polysaccharide for pulmonary disorder
  • Diagnostic drug administered to the bladder
  • Drug for in vitro treatment of sperm
  • Synthetic protein to treat HIV
  • Solution used in continuous renal replacement therapy procedures
  • Vitreous liquefaction agent
  • Oxygen-carrying liquid drug to treat pulmonary conditions
  • Antibiotic cream to treat nasal infections
  • Agent to decontaminate chemical and biological warfare agents
  • Extended-release synthetic compound for orthopedic use
  • Isotope-based drug combination to diagnose digestive disease
  • Topical agent for wound healing
  • Recombinant hormone for the treatment of obesity
  • Synthetic protein to treat chemotherapy side effect
  • Hydroxyapatite-based dentifrice
  • Solution for use in cardioplegia and preservation of the heart during cardiac surgery
  • Enzyme to degrade viscoelastic agent during cataract surgery
  • Synthetic immunomodulator for neurological use
  • Drug used in therapeutic ultrasound procedures
  • Polysaccharide for prevention/treatment of bacterial overgrowth
  • Heat-activated chemotherapy drug

B. Biological Products

  • Botulinum toxin for treatment of neuromuscular disorders
  • Recombinant protein for dental use
  • Monoclonal antibodies for treatment of blood disorder

C. Combination Products with Drug Primary Mode of Action

  • Cytotoxic agent and biological product for targeted cancer treatment
  • Gynecologic drug and delivery device
  • Photosensitizing drug and light source for cancer treatment
  • Drug and transdermal iontophoretic delivery system
  • Fluoride-containing dental device for anticaries treatment
  • Fluoride varnish for anticaries treatment
  • Drug with injector to treat erectile dysfunction
  • Drug with injector to treat anaphylactic reactions
  • Drug with implantable delivery device
  • Antiseptic skin preparation swabs
  • Peritoneal dialysis solution and administration set
  • Drug and delivery device for diagnosis of coronary artery disease
  • Drug and delivery system for cancer treatment
  • Drug and radiation emitting device to treat cancer
  • Drug and delivery system for use with vein grafts
  • Antimicrobial barrier
  • Spermicidal gel with delivery device
  • Antibiotic with biodegradable delivery device
  • Drug reconstitution and delivery system
  • Contrast agent and saline flush syringes
  • Chemoablation drug and delivery device
  • Cytotoxic agent and enzyme for cancer treatment
  • Drug and drainage device for glaucoma treatment
  • Drug and delivery system for localized bladder treatment
  • Drug and device for ex vivo photodynamic cancer treatment
  • Hormone to induce expression of breast fluids and sample collection device
  • Enzymatic debriding agent/dressing for wound management
  • Insulin and inhaler to treat diabetes
  • Synthetic drug with controlled-delivery device for ophthalmic use
  • Chemical agent and delivery system for gallstone dissolution
  • Chlorhexidine gluconate swabs
  • Radiolabeled contrast agent, production device and administration set
  • Aerosolized radiolabeled contrast agent and production device
  • Radiopharmaceutical and carrier for orthopedic use
  • Drug and delivery system for internal tissue
  • Photopheresis system and drug to treat skin cancer
  • Drug, antibody and enzyme for cancer treatment
  • PET drug and probe for tumor localization
  • Topical drug and light source to treat skin cancer
  • Patient-controlled transdermal system for pain management
  • Drug and light source for dental use
  • Drug and collagen combination for pain relief after lumbar surgery
  • Aerosolized sodium chloride for halotherapy
  • Prefilled insulin cartridges for use with a dedicated infusion pump
  • Drug-eluting device to prevent restenosis of vascular grafts
  • Condom with drug-containing gel to help maintain erection
  • Cytotoxic agent-monoclonal antibody conjugate for cancer treatment
  • Cartridges with prefilled syringes for use in specified reusable autoinjector

D. Combination Products with Biological Product Primary Mode of Action

  • Cytotoxic monoclonal antibodies with device to remove excess antibodies from patient
  • Bone morphogenetic proteins and collagenous matrices for bone regeneration
Back to Top